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Nonsyndromic oral clefts are considered a problem of public health in Brazil, presenting a multifactorial etiology that involves genetic and environmental components, such 
as maternal alcohol consumption. Several candidate genes have been investigated to 
identify some association with nonsyndromic clefts risk. The epidermal growth factor 
(EGF) gene is implicated in the normal craniofacial development and its functional +61 
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cancer and oral clefts may share the same molecular pathways. Objective: Our goal was 
!	

	

oral clefts susceptibility. Material and Methods: The case-control study included 218 
cleft cases and 253 controls from Brazil. The control group was comprised of individuals 
without congenital malformations, dental anomalies and family history of clefts. The cleft 
phenotypes and subphenotypes were determined based on clinical examination. Genomic 
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polymorphism genotype was determined by polymerase chain reaction-restriction fragment 
length polymorphism. Results: We noticed the association between maternal alcohol 
consumption during pregnancy and cleft occurrence. The A allele and AA genotype were 
over-represented in cleft cases compared with control group when we considered the 
bilateral cleft lip with or without cleft palate (CL±P) cases, cleft cases with tooth agenesis 
and cleft cases presenting family history of cleft, but the differences were not statistically 
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control group, showing a borderline p value. Comparing the different cleft phenotypes, 
we observed statistical differences between CP and CL±P cases. Our data suggest the 
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in a Brazilian population, but supported the different genetic background between CL±P 
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risk in our population.
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INTRODUCTION
Congenital malformations comprise 2-3% of all 
human live births, being one of the major causes of 
childhood mortality in developed countries. The oral 
clefts are the most common craniofacial anomaly 
in humans, affecting approximately one in every 
500 to 1,000 live births worldwide25. In Brazil, the 
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estimated prevalence is 0.36 in 1,000 live births and 
the Southeast region shows a prevalence of 0.34 per 
1,000 live births27.
Besides the facial abnormalities, individuals 
affected present several complications such as 
speech, hearing and dental disorders. Associated 
defects, especially involving cardiovascular, central 
nervous and musculoskeletal systems, are commonly 
seen, as well as the psychosocial effects from the 
malformation experienced lifelong18.
The oral clefts arise from failure of normal 
craniofacial developmental processes that require 
the coordination of a complex series of events 
involving cell growth, migration, differentiation, and 
apoptosis18. Nonsyndromic oral clefts are observed 
in approximately 70% of the cases, occurring as 
an isolated condition unassociated with any other 
recognizable anomalies28. In Brazil, this defect is 
considered a problem of public health, since about 
4,000 new cases are expected every year4.
The nonsyndromic oral clefts are composed of two 
separate entities: cleft lip with or without cleft palate 
(CL±P) and cleft palate only (CP). Moreover, evidences 
show that CL±P and CP are developmentally distinct 
entities. Despite the efforts that have been made to 
elucidate the oral clefts etiology, the understanding 
about nonsyndromic variants still remains unknown11. 
In general, nonsyndromic oral clefts are considered 
being from a multifactorial origin, involving mainly 
environmental and genetic components25. Regarding 
the environmental components, mother’s habits such 
as alcohol intake and smoking during pregnancy 
are pointed out as risk factors to oral clefts17. On 
the other hand, recent advances into both genetics 
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for promoting an increase in the knowledge about 
the basis of craniofacial development, bringing a 
number of genes associated with mammals cleft 
development.
Several candidate genes have been investigated 
to identify some association with nonsyndromic 
clefts, including growth factors such as EGF5,24. A 
single gene on chromosome 4q25-q27 encodes the 
epidermal growth factor (EGF). EGF has an effect on 
the differentiation and is a potent mitogenic factor 
for a variety of cultured cells of both ectodermal 
and mesodermal origin. The protein EGF binds 
to its receptor (EGFR), leading to a signaling 
transduction cascade activation that will ultimately 
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differentiation. EGF is expressed in several developing 
organs and it has been implicated to play roles 
in odontogenesis15, mandibular morphogenesis30, 
embryogenesis and also normal palate development13. 
It has been suggested that EGF contributes to 
a successful fusion of the facial prominences and 
outgrowth of the primary palate13. Also, changes in 
EGF expression affecting the proliferation of epithelial 
cells have been related to cleft palate development1.
Genetic variations in the EGF may lead to an 
alteration in the protein production and activity, 
affecting an individual susceptibility to many types of 
conditions, including oral clefts. A single nucleotide 
polymorphism (SNP) in the 5' untranslated region 
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an A to G transversion found 61bp downstream of 
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vitro analysis suggested changes in EGF expression 
levels caused by this base substitution29. The 
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widely studied variation in the EGF gene and it has 
been associated with increased risk of many types of 
cancer, including melanoma29, glioma12, hepatocellular 
carcinoma21, among others. Interestingly, some 
reports have observed the association between 
congenital malformation and cancer7,8, suggesting 
that the individuals born with oral clefts have a 
higher susceptibility for cancer, raising the hypothesis 
that, in some instances, these two conditions share 
common molecular pathways.
Afterwards, considering the potential implication 
of EGF gene polymorphism affecting the normal 
craniofacial development and its relation with 
cancer susceptibility, we assessed the association 
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nonsyndromic oral clefts risk in a Brazilian population.
MATERIAL AND METHODS
Subjects
The local Research and Ethics Committee approved 
this study under protocol number 0132.314.000-09. 
Informed consent was obtained from all participating 
individuals or parents/legal guardians.
Two hundred eighteen (218) patients with 
cleft and in absence of any known cleft associated 
syndrome were recruited (mean age: 17.2±10.8 
years old). None of the index cases were diagnosed 
with median cleft. Index cases were ascertained 
through the Hospital Municipal Nossa Senhora do 
Loreto (Reference Hospital for Oral Cleft Treatment), 
located in Rio de Janeiro, Brazil.
The determination of the cleft phenotype was 
based on the clinical examination. Cleft status was 
based on cleft laterality (left, right and bilateral) and 
cleft severity (comprised of primary and secondary 
palates entirely). Abbreviations for cleft type 
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CL±P - cleft lip+cleft lip and palate excluding cleft 
palate only.
Tooth agenesis was considered when at least 
one developmentally missing permanent tooth was 
observed. This condition represents an important 
factor in the cleft subphenotypes determination. 
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Only dental anomalies outside the cleft area were 
considered for CL and CLP. For the CP subjects, all 
dental anomalies observed were considered. Dental 
anomalies adjacent to the cleft area (affecting 
maxillary central incisors, lateral incisors, or 
canines) were not included in this study because the 
absence of such teeth may be the consequence of 
developmental anomalies at the cleft site19.
The control group (n=253) was selected among 
patients and workers in School of Dentistry at Federal 
University of Rio de Janeiro (mean age: 20.4±16.4 
years old). Individuals were eligible as a control 
only if they had no congenital malformations, dental 
anomalies and family history of oral clefts.
All the evaluated subjects were recruited 
from July to December 2009. Epidemiological 
data such as ethnicity, family history of clefts 
and mother’s habits during pregnancy including 
cigarette smoking and alcohol consumption were 
obtained by standardized questionnaires. The 
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reported information. Both institutions where the 
subjects were recruited are located in the Rio de 
Janeiro state, in the Southeast of Brazil, one of the 
most densely populated and industrialized regions 
of the country. This region comprises an ethnic 
admixture of Caucasians (47.4%) and African descent 
(52.0%). The remaining 0.6% of the population is of 
Amerindian or Asian descent9.
PCR-RFLP
Genomic DNA for molecular analysis was extracted 
from cells detached of oral mucosa by mouthwash 
using SDS and proteinase k digestion16&'
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polymorphism using the polymerase chain reaction 
- restriction fragment length polymorphism (PCR-
RFLP) technique as previously described29. The PCR 
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ng of genomic DNA, 1x Dream Taq Buffer (Fermentas, 
Maryland, USA), 0.2 mM of dNTPs (Fermentas, 
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TTCACAGAGTTTAACAGCCC 3’ – Invitrogen, CA, USA) 
and 1 U Dream Taq DNA Polymerase (Fermentas, 
Maryland, USA). The cycling conditions comprised 
an initial denaturation step for 10 min at 96°C, 
followed by 44 cycles consisting of three steps: 96°C 
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extension step was performed at 72°C for 10 min. 
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U of Alu I (New England Biolabs, Maryland, USA) at 
37°C overnight, electrophoresed on a 2.5% agarose 
gel stained with ethidium bromide and photographed 
under UV illumination. The digestion produced four 
fragments (15, 34, 91 and 102bp) when the A allele 
was present and three fragments (15, 34 and 193 
bp) in the presence of the G allele.
Statistical analysis
The data were processed and analyzed by using 
the GraphPad Instat (version 6.0) software. Odds 
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if any phenotype and subphenotype of oral cleft was 
preferentially associated with EGF genotypes and 
alleles. Moreover, the Hardy-Weinberg equilibrium 
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versus the expected genotype frequencies.
RESULTS
The characteristics of the studied population are 
summarized in Table 1. Out of the 471 individuals 
included in the study, 218 presented clefts and 253 
did not (controls). In the cleft group, 87.6% had CL±P 
(20.4% of CL and 79.6% of CLP) and 12.4 % had CP.
The occurrence of cleft was associated to maternal 
alcohol consumption during pregnancy (p=0.04). The 
distribution of cleft type was statistically different 
according to gender with CP being more prevalent 
than CLP in females (Table 2). Considering the 
distribution of cleft type and laterality (bilateral or 
unilateral) or cleft severity (complete or incomplete) 
according to gender, no statistical differences were 
detected (data not shown).
Genotype distribution in cleft cases and controls 
was compared to evaluate the EGF+61 polymorphism 
association with clefts susceptibility. The banding 
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are showed in Figure 1.
The polymorphism genotype distributions in 
cases and controls were shown in Table 3 and were 
consistent with those predicted from the Hardy-
Weinberg equilibrium. The heterozygous AG was 
the most frequent genotype in both studied groups. 
The distributions of genotypes and alleles were 
similar, considering all cleft cases versus controls 
and CL±P cases versus controls (Table 3). The same 
similarity was observed when all cleft cases and 
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and African descents (blacks and mulattos) and 
compared (p=0.063 and p=1.000, respectively) 
(data not shown). The AA genotype frequency in CP 
patients was lower than in the control group, showing 
a borderline p value (p=0.054).
The frequency of the A allele was higher in 
bilateral CL±P patients (54.6%), cleft cases with 
tooth agenesis (55.4%) and cleft cases presenting 
family history of cleft (56.3%) (data not shown) 
than in the control group, but no statistically 
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was over-represented in both bilateral CL±P and 
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the same pattern of genotype distribution was 
observed considering maternal smoking during 
pregnancy (23.9% and 16.2% in cases and controls, 
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any statistical difference.
Comparing the different entities of nonsyndromic 
oral clefts (CL±P versus CP), we noticed that the allele 
G was most frequent in CP cases (57.4%) compared 
with CL±P cases (47.4%) (Table 3). This difference 
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DISCUSSION
To the best of our knowledge, we here present 
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risk. According to Shahbazi, et al.29 (2002), this 
variant may act as a functional polymorphism since 
Population characteristics
Cleft Controls
(n=253)
p*
(n=218)
Gender, n (%)
Female 104 (47.7) 138 (54.5) 0.14
Male 114 (52.3) 115 (45.5)
Ethnicity, n (%)
Caucasian 128 (58.7) 153 (60.5) 0.70
African descent 90 (41.3) 100 (39.5)
Mother's habits during pregnancy, n (%)
Cigarette smoking 46 (21.1) 37 (14.6) 0.07
Alcohol consumption 26 (11.9) 16 (6.3) 0.04
Cleft group characteristics
CL CLP CP
(n=39)  (n=152) (n=27)
Cleft side, n (%)
Left 24 (61.6) 70 (46.1) -
Right 10 (25.6) 33 (21.7) -
Bilateral 5 (12.8) 49 (32.2) -
Severity of cleft, n (%)
Complete - 148 (97.4) 22 (81.5)
Incomplete -   4 (2.6) 5 (18.5)
Associated tooth agenesis, n (%) 4 (10.5) 22 (14.4) 2 (7.4)
Positive cleft family history, n (%) 8 (21.1) 38 (24.8) 4 (14.8)
*Fisher's exact test
CL: cleft lip; CLP: cleft lip and palate; CP: cleft palate only
Table 1- Descriptive characteristics of cleft patients and controls
Cleft type CL CLP CP p*
Gender (n=39) (n=152) (n=27)
Males, n (%) 16 (41.0) 89 (58.6) 9 (33.3)
0.02
Females, n (%) 23 (59.0) 63 (41.4) 18 (66.7)
*Chi-square test
CL versus CLP: p=0.07 (Fisher's exact test) 
CL versus CP: p=0.61 (Fisher's exact test)
CLP versus CP: p=0.02 (Fisher's exact test)
CL: cleft lip; CLP: cleft lip and palate; CP: cleft palate only
Table 2- Distribution of cleft type according to gender
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the base substitution can lead to changes in the 
EGF protein production. Moreover, the association 
of this polymorphism with clinical disorders including 
cancer has been described. Since cancer and oral 
clefts may share the same molecular pathways, the 
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nonsyndromic oral clefts risk.
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polymorphism and cancer susceptibility is known, 
as well as the fact that risk allele vary between 
distinct ethnicities. The G allele and GG genotype 
were associated with increased risk for gliomas in 
the European population and represent protective 
factors in the Chinese population12,32. Considering a 
Brazilian population from Rio de Janeiro, a high risk 
for gliomas was associated with the A allele and AA 
genotype31.
According to our results when evaluating 
nonsyndromic oral cleft patients, the A allele and 
AA genotype were over-represented in cleft cases 
compared to control group when we considered 
the bilateral CL±P cases, cleft cases with tooth 
agenesis and cleft cases presenting family history 
of cleft. However, we did not observe a statistically 
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one limitation of our study could be the sample size 
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oral cleft susceptibility in the population evaluated. 
Subjects n Alleles n (%) p* OR (95%CI) Genotypes n (%) p*
A G AA AG GG
Controls 253 252 (49.8) 254 (50.2) - Reference 60 (23.7) 132 (52.2) 61 (24.1)
All Clefts 218 224 (51.4) 212 (48.6) 0.65 1.06 (0.82-1.38) 52 (23.9) 120 (55.0) 46 (21.1) 0.72
Cleft Type
CL±P 191 201 (52.6) 181 (47.4) 0.42 1.12 (0.86-1.46) 50 (26.2) 101 (52.9) 40 (20.9) 0.68
CP 27 23 (42.6) 31 (57.4) 0.32 0.75 (0.42-1.32) 2 (7.4) 19 (70.4) 6 (22.2) 0.11
Cleft 
Subphenotype
Bilateral CL±P 54 59 (54.6) 49 (45.4) 0.40 0.82 (0.54-1.25) 16 (29.6) 27(50.0) 11 (20.4) 0.63
Unilateral CL±P 137 142 (51.8) 132 (48.2) 0.60 0.92 (0.69-1.24) 34 (24.8) 74 (54.0) 29 (21.2) 0.80
Left CL±P 94 98 (52.1) 90 (47.9) 0.61 0.91 (0.65-1.27) 20 (21.3) 58 (61.7) 16 (17.0) 0.24
Right CL±P 43 44 (51.2) 42 (48.8) 0.91 0.93 (0.60-1.50) 14 (32.6) 16 (37.2) 13 (30.2) 0.19
Cleft with tooth 
agenesis
28 31 (55.4) 25 (44.6) 0.48 1.25 (0.72-2.18) 8 (28.6) 15 (53.6) 5 (17.8) 0.71
Table 3- Association between EGF+61 A>G polymorphism and clefts risk
*Fisher’s exact test or chi-square test
EGF: epidermal growth factor; CL±P: cleft lip+cleft lip and palate excluding cleft palate only; CP: cleft palate only
Figure 1- PCR-RFLP of EGF+61 A>G polymorphism. Agarose gel electrophoresis of EGF DNA fragments stained with 
ethidium bromide. Lane 1:100bp DNA Ladder; Lanes 2-5, 8 and 9: heterozygous AG; Lanes 6 and 7: homozygous AA; 
Lane 10: homozygous GG. PCR-RFLP: polymerase chain reaction - restriction fragment length polymorphism; EGF: 
epidermal growth factor
FALAGAN-LOTSCH P, LOPES TS, KÜCHLER EC, TANNURE PN, COSTA MC, AMORIM LMF, GRANJEIRO JM
2015;23(4):390-96
J Appl Oral Sci. 395
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association between two others EGF gene variations 
and nonsyndromic oral clefts.
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between populations, consistent with the possibility 
of false associations in case-control studies due to 
ethnic admixture. Any polymorphism found by chance 
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appear to be associated with disease and will likely 
be a false positive. The Brazilian population is multi-
ethnic, consisting mainly of people from European, 
African, and South Amerindian origin, being one of 
the most heterogeneous population in the world. Not 
surprisingly, our population presents large levels of 
genetic admixture. A study predicting the level of 
Brazilians African ancestry estimated by molecular 
biomarkers showed the Brazilian population presents 
African ancestry values intermediate between 
Europeans and Africans. Moreover, the southeast 
region of the country showed the most pronounced 
level of admixture. To prevent false-positive 
associations, the studied population in the present 
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and the polymorphism frequencies were evaluated. 
The alleles’ distribution were similar between whites 
(Caucasian) and non-whites (mulattos and blacks).
Genetic predisposition studies on human 
populations have demonstrated that CL±P and CP 
have distinct genetic backgrounds. In the present 
study, the EGF genotype distribution between 
CL±P and CP patients was statistically different 
being the AA genotype over-represented in CL±P 
cases and the GG genotype more common in CP 
cases. Genome Wide Association Studies (GWAS) 
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susceptibility such as 1q32, 8q24, 10q25, 17q22, 
2p21, 13q31, and 15q2222,23. However, the same 
'
*4
assessed23, suggesting that these clefting phenotypes 
have distinct etiologies and supporting the historical 
separation of CL±P from CP.
Despite different research groups have performed 
notable attempts in the last decades to locate 
nonsyndromic clefts loci in the human genome, 
advances are still modest. The inheritance cannot be 
explained by a Mendellian simple model, displaying a 
very familial aggregation, which reveals the presence 
of an important genetic component. Mutations 
associated with genes of the EGF superfamily are 
implicated in malformations arising from abnormal 

%'5. Also, it was 
suggested the EGF as candidate gene to clefting since 
it plays a role in normal and abnormal palatogenesis 
in rodents1,13.
The possible interaction between EGF and other 
clefting-related genes in the same pathway, such 
as EGFR and TGFA (Transforming Growth Factor 
Alpha), may contribute to the nonsyndromic oral 
clefts susceptibility. It has been suggested that EGF, 
TGFA and EGFR play a role in cell proliferation and 
differentiation during primary palate morphogenesis 
which would then be relevant to clefting13. The 
teratogenic 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) exposure has been shown to disrupt EGF, 
EGFR and TGFA expression in the mice palate 
affecting the proliferation and differentiation of the 
medial epithelial cells resulting in cleft palate1.
Overall, TGFA as well as IRF6 are considered 
 %
' 
[/
mutations in TGFA gene were not associated with 
nonsyndromic cleft lip and palate in the Brazilian 
population6 and the role of IRF6 in our population is 
still unclear10. On the other hand, some variations 
such as polymorphisms in MMP3 and its inhibitor 
TIMP220, BMP42, and some markers discovered by 
GWAS, such as 1p36, 15q22 and 17p224 showed 
'	
%
in recent studies with individuals from Brazil. A BMP4 
polymorphism was also associated with upper lateral 
incisor agenesis considered a microform of CL in a 
Southeast Brazilian population3.
The association of a number of environmental 
factors and cleft risk has been reported, including 
maternal alcohol intake during pregnancy14. In the 
present study, we observed a relation between the 
increase of odds for CL±P and CP and maternal 
exposure to alcohol, in agreement with results 
obtained in a Brazilian case-control study17.
Another well-established environmental factor for 
cleft risk is maternal smoking during pregnancy14. 
Despite the high frequency of the AA genotype in cleft 
cases considering mother´s cigarette smoking during 
pregnancy in the present study, maternal smoking 
!	


and the nonsyndromic oral clefts risk.
It has been proposed that tooth agenesis outside 
%
;%'
of cleft subphenotypes19. So, we included tooth 
agenesis as a subgroup of oral cleft and observed 
that the A allele was more frequent in the cleft cases 
with tooth agenesis compared with controls, with no 
statistical difference.
In summary, our data suggest that the EGF+61 
	

	

oral cleft susceptibility in a population from the 
Southeast of Brazil. However, our results supported 
a different genetic background between CL±P and 
CP. The potential effect of maternal alcohol intake on 
%;'

Z^
studies improving the statistical power and using 
high-throughput screening methods are needed to 
elucidate the role of this and others SNPs in candidate 
genes as contributors to nonsyndromic oral clefts risk.
The functional EGF+61 polymorphism and nonsyndromic oral clefts susceptibility in a Brazilian population
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